AI assistant
Sending…
Genmab — Director's Dealing 2019
Apr 4, 2019
3365_rpt_2019-04-04_e34a9a3b-ae78-491d-9a60-065d65c69b35.pdf
Director's Dealing
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | Anders Gersel Pedersen | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Member of the Board of Directors | ||||
| b) | Initial notifica tion/Amendment |
Initial notification | ||||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||||
| a) | Name | Genmab A/S | ||||
| b) | LEI | 529900MTJPDPE4MHJ122 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) | Description of the financial instrument, type of instru ment |
Share | ||||
| Identification code | DK0010272202 | |||||
| b) | Nature of the transaction | Sale of shares | ||||
| c) | Price(s) and volume(s) | Price(s) DKK 1,172.40 |
Volume(s) 9,000 |
|||
| d) | Aggregated information - Aggregated volume - Price |
|||||
| e) | Date of the transaction | 2019-04-04 | ||||
| f) | Place of the transaction | Aquis Exchange (AQXE) CBOE Europe (BATD, BATE, CHID and CHIX) Credit Suisse (SICS) Nasdaq Copenhagen (DCSE, MCSE and XCSE) Posit (XPAC and XPOS) Turquoise (TRQM and TRQX) UBS (XUBS) |

| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Jan van de Winkel | |||
| 2. | Reason for the notification | ||||
| a) | Position/status | President & Chief Executive Officer | |||
| b) | Initial notifica tion/Amendment |
Initial notification | |||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | |||
| a) | Name | Genmab A/S | |||
| b) | LEI | 529900MTJPDPE4MHJ122 | |||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instru ment |
Share | |||
| Identification code | DK0010272202 | ||||
| b) | Nature of the transaction | Sale of shares | |||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
| DKK 1,172.40 | 42,400 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
|||||
| - Price |
|||||
| e) | Date of the transaction | 2019-04-04 | |||
| f) | Place of the transaction | Aquis Exchange (AQXE) CBOE Europe (BATD, BATE, CHID and CHIX) Credit Suisse (SICS) Nasdaq Copenhagen (DCSE, MCSE and XCSE) Posit (XPAC and XPOS) Turquoise (TRQM and TRQX) UBS (XUBS) |

| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | David Andrew Eatwell | ||
| 2. | Reason for the notification | |||
| a) | Position/status | Executive Vice President & Chief Financial Officer | ||
| b) | Initial notifica tion/Amendment |
Initial notification | ||
| 3. | tion monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc | ||
| a) | Name | Genmab A/S | ||
| b) | LEI | 529900MTJPDPE4MHJ122 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instru ment |
Share | ||
| Identification code | DK0010272202 | |||
| b) | Nature of the transaction | Sale of shares | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 1,172.40 | 45,000 | |||
| d) | Aggregated information | |||
| - Aggregated volume |
||||
| - Price |
||||
| e) | Date of the transaction | 2019-04-04 | ||
| f) | Place of the transaction | Aquis Exchange (AQXE) CBOE Europe (BATD, BATE, CHID and CHIX) Credit Suisse (SICS) Nasdaq Copenhagen (DCSE, MCSE and XCSE) Posit (XPAC and XPOS) Turquoise (TRQM and TRQX) UBS (XUBS)urquoise (TRQM and TRQX) |
More from Genmab
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Foreign Filer Report
2026
May 7
Foreign Filer Report
2026
Apr 17
Foreign Filer Report
2026
Apr 17
Share Issue/Capital Change
2026
Apr 17
Share Issue/Capital Change
2026
Apr 17
Foreign Filer Report
2026
Apr 14
Major Shareholding Notification
2026
Apr 14